Positioning & Category Design — Within3

Put the "life" back in life sciences.

Two engagements with a life sciences platform trusted by 18 of the top 20 pharmaceutical companies — first sharpening its positioning, then designing the category that would unify three companies into one.

Client
Within3
Agency
Gold Front
Years
2020–2021
Scope
Positioning, Category Design

The challenge

Within3 built virtual engagement tools for pharmaceutical companies — advisory boards, expert discussions, medical affairs work. The first engagement positioned the core product: the enterprise discussion platform for life sciences. Then the company acquired rMark and Voxx, and the challenge changed shape: three products, three stories, one company that needed a single category to stand in.

The insight

The research surfaced a costly rhythm problem in pharma: advisory board cycles ran nine to twelve months, and companies leaned too heavily on the same small circle of key opinion leaders. Within3's platform compressed those cycles to roughly three months — but "faster ad boards" is a feature, not a category.

The real product wasn't discussion. It was insight — captured, managed, and put to work.

The category

The category work developed and pressure-tested naming candidates for the unified platform, with "Insights Management Platform" among the leading directions — the framing Within3 publicly adopted. The story moved the company from a tool you schedule to a system of record for what the world's experts think.

What we delivered

Positioning strategy for the core platform. Category design workshops uniting Within3, rMark, and Voxx post-acquisition. Category naming and messaging. A headline that kept the humanity in an enterprise story: put the "life" back in life sciences.